Tune Therapeutics, Inc.

Calculating rank

USPTO Granted Patents = 6

Trademarks = 1

Forward Citations = 5

Loading Chart...

7 inventors (with patents filed for the assignee):

Kendra Congdon (6 out of 6 patents)

Veronica Gough (5 out of 6 patents)

Joshua B Black (5 out of 7 patents)

4. Jason Dean (5 out of 5 patents)

5. Brian Cosgrove (5 out of 5 patents)

6. Britta Jones (5 out of 5 patents)

7. Jennifer Kwon (1 out of 1 patent)

6 patents: Sort by Forward Citations

1. 12398394 - Compositions, systems, and methods for regulation of Hepatitis B virus through targeted gene repression (2025-08-26),

2. 12325858 - Compositions, systems, and methods for regulation of Hepatitis B virus through targeted gene repression (2025-06-10),

3. 12325857 - Compositions, systems, and methods for regulation of Hepatitis b virus through targeted gene repression (2025-06-10),

4. 12252692 - Compositions, systems, and methods for regulation of hepatitis B virus through targeted gene repression (2025-03-18),

5. 12221608 - Compositions, systems, and methods for regulation of hepatitis b virus through targeted gene repression (2025-02-11),

6. 12098399 - Compositions, systems, and methods for epigenetic regulation of proprotein convertase subtilisin/kexin type 9 (PCSK9) gene expression (2024-09-24),

Company Overview

Tune Therapeutics is a biotechnology company focused on developing innovative therapies that harness the power of epigenetics to treat a range of diseases. By utilizing their proprietary platform, they aim to precisely modulate gene expression to create targeted treatments with improved efficacy and safety profiles.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

6 Patents

#314 in Seattle, WA

#1,070 in Washington

#45,027 in US

Seattle, WA, United States of America